Merck nears $6 billion all-cash deal to buy Terns Pharma, FT reports
Reuters
8 hours ago
Merck nears $6 billion all-cash deal to buy Terns Pharma, FT reports
March 24 (Reuters) - Merck MRK.N is nearing a roughly $6 billion all-cash deal to buy biotech firm Terns Pharma TERN.O, the Financial Times reported on Tuesday, citing people familiar with the matter.
Talks between Merck and Terns were at an advanced stage and a deal could be reached in the coming days, the report added.
Merck and Terns Pharma did not immediately respond to Reuters' request for comment.
(Reporting by Fabiola Arámburo in Mexico City; Editing by Sherry Jacob-Phillips)
((Fabiola.Solano@thomsonreuters.com))
At the request of the copyright holder, you need to log in to view this content
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.